Spotlight on crizotinib in the first-line treatment of ALK-positive advanced non-small-cell lung cancer: patients selection and perspectives

Etienne Giroux Leprieur,1,2 Vincent Fallet,3,4 Jacques Cadranel,3,4 Marie Wislez3,4 1Respiratory Diseases and Thoracic Oncology Department, APHP-Ambroise Paré Hospital, Boulogne-Billancourt, France; 2EA4340 Laboratory, UVSQ, Paris-Saclay University, France; 3Respiratory Diseases Departmen...

Full description

Saved in:
Bibliographic Details
Main Authors: Giroux Leprieur E, Fallet V, Cadranel J, Wislez M
Format: article
Language:EN
Published: Dove Medical Press 2016
Subjects:
Online Access:https://doaj.org/article/2059dbbae5964960a6fa029619e4506f
Tags: Add Tag
No Tags, Be the first to tag this record!